Concepedia

David P. Macfarlane

DP

14

Publications

4.3K

Citations

13

H-Index

1999

Active since

Affiliations

University of Edinburgh(Current)

The Queen's Medical Research Institute

University of Glasgow

Queen's Medical Centre

NHS Highland

David P. Macfarlane is an author at University of Edinburgh specializing in metabolic syndrome, diabetes, and medicine.

Top concepts

Publications per year

1999–2021

14

Publications

14

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

, , +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

, , +10

Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome

David P. Macfarlane, Shareen Forbes, Brian R. Walker · Journal of Endocrinology · 2008 · 373 citations · Full text

, , +18

One-Hour Plasma Glucose Identifies Insulin Resistance and β-Cell Dysfunction in Individuals With Normal Glucose Tolerance

Melania Manco, Simona Panunzi, David P. Macfarlane et al. · Diabetes Care · 2010 · 102 citations · Full text

5α-Reductase Type 1 Deficiency or Inhibition Predisposes to Insulin Resistance, Hepatic Steatosis, and Liver Fibrosis in Rodents

Dawn E. W. Livingstone, Pascal Barat, Emma M. Di Rollo et al. · Diabetes · 2014 · 96 citations · Full text

Rows per page

1–5 of 14